Suppr超能文献

侧卧位微创经皮肾取石术与后腹腔镜下离断性肾盂成形术治疗鹿角形肾结石的临床对比。

Clinical comparison of lateral supine position mini-percutaneous nephrolithotomy and anatrophic nephrolithotomy in the treatment of complete staghorn renal calculi.

机构信息

Department of Urology, Affiliated Hospital of Zunyi Medical University, Zunyi, 563000, Guizhou, China.

出版信息

BMC Urol. 2024 Aug 7;24(1):167. doi: 10.1186/s12894-024-01555-z.

Abstract

BACKGROUND

At present, the guidelines for urology recommend percutaneous nephrolithotomy (PCNL) as the preferred treatment for staghorn renal calculi (SRC). However, for complete SRC, it has been questioned by clinicians and patients due to high residual stone rate, complications, repeated hospitalizations and high treatment cost. Anatrophic nephrolithotomy (ANL) is a traditional and classic method for the treatment of SRC. Due to its high trauma and high technical requirements, it is difficult to carry out in primary hospitals, and gradually replaced by PCNL. The purpose of this study is to compare the efficacy of PCNL and ANL in the treatment of complete SRC.

METHODS

Overall, 238 patients with complete SRC were divided into mini-PCNL in lateral supine position group, (n = 190) and ANL group (n = 94) according to treatment for a retrospective cohort study. The calculi parameters, renal function index, comorbidities of calculi, surgical complications, length and frequency of hospitalization, treatment costs, results of postoperative satisfaction survey were compared between the two groups.

RESULTS

The risk of the residual stone rate after mini-PCNL in lateral supine position was 239 times (OR = 238.667, P < 0.0001), the number of residual stone 1.3 times (OR = 1.326, P < 0.0001), the amount of residual stone 2.2 times (OR = 2.224, P < 0.0001) that of ANL. The risk of the cost of initial treatment after mini-PCNL in lateral supine position was 3.3 times (OR = 3.273, P < 0.0001), the total cost of treatment 4 times (OR = 4.051, P < 0.0001), the total length of hospital stays 1.4 times (OR = 1.44, P < 0.0001) that of ANL, the incidence of postoperative renal atrophy was 2.2 times (OR = 2.171, P = 0.008) higher in the ANL than in the mini-PCNL in lateral supine position. Glomerular filtration rate (GFR) reduction after ANL was 1.4 times (OR = 1.381, P = 0.037) greater than that after mini-PCNL in lateral supine position at 24-month follow-up. The risk of the overall satisfaction of ANL was 58 times (OR = 57.857, P < 0.0001) higher than that of mini-PCNL in lateral supine position, the number of branches of staghorn greater than 8 is a high risk factor for the occurrence of residual stone after mini-PCNL in lateral supine position (OR = 353.137, P < 0.0001).

CONCLUSION

Although the risk of renal atrophy and decreased GFR after ANL is higher than that of mini-PCNL in lateral supine position, the efficacy of traditional ANL in the treatment of complete SRC was generally superior to that of mini-PCNL in lateral supine position. Moreover, number of branches of staghorn greater than 8 are the preferred ANL for complete SRC.

TRIAL REGISTRATION

ChiCTR2100047462. The trial was registered in the Chinese Clinical Trial Registry; registration date: 19/06/2021.

摘要

背景

目前,泌尿科指南建议经皮肾镜取石术(PCNL)作为鹿角状肾结石(SRC)的首选治疗方法。然而,对于完全性 SRC,由于残留结石率高、并发症多、反复住院和治疗费用高,临床医生和患者对此提出了质疑。后腹腔镜肾切开取石术(ANL)是治疗 SRC 的传统经典方法。由于其创伤大、技术要求高,在基层医院难以开展,逐渐被 PCNL 所取代。本研究旨在比较 PCNL 和 ANL 治疗完全性 SRC 的疗效。

方法

回顾性队列研究中,根据治疗方法将 238 例完全性 SRC 患者分为侧卧位微创 PCNL 组(n=190)和 ANL 组(n=94)。比较两组结石参数、肾功能指标、结石合并症、手术并发症、住院时间和频率、治疗费用、术后满意度调查结果。

结果

侧卧位微创 PCNL 后残留结石率的风险是 ANL 的 239 倍(OR=238.667,P<0.0001),残留结石数量是 ANL 的 1.3 倍(OR=1.326,P<0.0001),残留结石量是 ANL 的 2.2 倍(OR=2.224,P<0.0001)。侧卧位微创 PCNL 初始治疗费用的风险是 ANL 的 3.3 倍(OR=3.273,P<0.0001),治疗总费用是 ANL 的 4 倍(OR=4.051,P<0.0001),总住院时间是 ANL 的 1.4 倍(OR=1.44,P<0.0001),术后发生肾萎缩的风险是 ANL 的 2.2 倍(OR=2.171,P=0.008)。侧卧位微创 PCNL 后肾小球滤过率(GFR)下降的风险是 ANL 的 1.4 倍(OR=1.381,P=0.037)。24 个月随访时,ANL 的总体满意度风险是侧卧位微创 PCNL 的 58 倍(OR=57.857,P<0.0001)。鹿角状分支数大于 8 是侧卧位微创 PCNL 后残留结石发生的高危因素(OR=353.137,P<0.0001)。

结论

虽然 ANL 后肾萎缩和 GFR 下降的风险高于侧卧位微创 PCNL,但传统 ANL 治疗完全性 SRC 的疗效普遍优于侧卧位微创 PCNL。此外,鹿角状分支数大于 8 是完全性 SRC 首选的 ANL。

临床试验注册号

ChiCTR2100047462。该试验在中国临床试验注册中心注册;注册日期:2021 年 6 月 19 日。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3865/11304705/a9f92607e621/12894_2024_1555_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验